Detection of leishmania in unaffected mucosal tissues of patients with Cutaneous Leishmaniasis Caused by Leishmania (Viannia) Species

Journal of Infectious Diseases

Volumn 200, Issue 4, 2009, Pages 638-646

  Figueroa, Roger Adrian ^a   Lozano, Leyder Elena ^a   Romero, Ibeth Cristina ^a   Cardona, Maria Teresa ^a   Prager, Martin ^a   Pacheco, Robinson ^a   Diaz, Yira Rosalba ^a   Tellez, Jair Alexander ^a   Saravia, Nancy Gore ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

KINETOPLAST DNA; MINICIRCLE DNA;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONJUNCTIVA; FEMALE; HUMAN; HUMAN TISSUE; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA PANAMENSIS; MALE; MUCOSAL DISEASE; NONHUMAN; NOSE MUCOSA; PARASITE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN DISEASE; SKIN LEISHMANIASIS; SOUTHERN BLOTTING; TONSIL; ANIMAL; MIDDLE AGED; MUCOSA; PARASITOLOGY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE;

ADULT; AGED; ANIMALS; BLOTTING, SOUTHERN; FEMALE; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; YOUNG ADULT;

EID: 69149101972     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/600109     Document Type: Article

References (31)

1. Saravia NG, Holguin AF, McMahon-Pratt D, D'Alessandro A. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg 1985;34:714-720
2. Abdalla RE, El Hadi A, Ahmed MA, El Hassan AM. Sudan mucosal leishmaniasis. Trans R Soc Trop Med Hyg 1975;69:443-449
3. 3. Bametson RS, Ridley RS, Wheate HW A form of muco-cutaneous leishmaniasis in the Old World. Trans R Soc Trop Med Hyg 1978; 72: 516-518 (Pubitemid 9039304)
4. el-Hassan AM, Meredith SE, Yagi HI, et al. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment. Trans R Soc Trop Med Hyg 1995; 89:647-652
5. Barral A, Pedral-Sampaio D, Grimaldi Junior G, et al. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991; 44:536-546
6. Marsden P L-CE, Lago E, Cuba C, Barreto A, Costa JML, Jones TC. Human mucocutaneous leishmaniasis in Tres Braços, Bahia-Brazil, an area of Leishmania braziliensis transmission. III. Mucosal disease presentation and initial evolution. Rev Soc Bras Med Trop 1984; 17:179-186
7. Osorio LE, Castillo CM, Ochoa MT. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics. Am J Trop Med Hyg 1998;59:49-52.
8. al-Gindan Y, Kubba R, el-Hassan AM, Omer AH, Kutty MK, Saeed MB. Dissemination in cutaneous leishmaniasis. 3. Lymph node involvement. Int J Dermatol 1989; 28:248-254
9. Barral A, Guerreiro J, Bomfim G, Correia D, Barral-Netto M, Carvalho EM. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg 1995; 53:256-259
10. Martinez JE A, Arias L, Escobar MA, Saravia NG. Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: re-examination of haematogenous dissemination. Trans R Soc Trop Med Hyg 1992;86:392-394
11. Vergel C, Palacios R, Cadena H, et al. Evidence for Leishmania (Viannia) parasites in the skin and blood of patients before and after treatment. J Infect Dis 2006; 194:503-511
12. Marsden PD. Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Tres Braços, Bahia-Brazil. Rev Soc Bras Med Trop 1994;27:93-101.
13. 13. Boaventura VS, Cafe V, Costa J, et al. Concomitant early mucosal and cutaneous leishmaniasis in Brazil. Am J Trop Med Hyg 2006; 75:267-269 (Pubitemid 46941342)
14. 14. Weigle KA, de Davalos M, Heredia P, Molineros R, Saravia NG, D'Alessandro A. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 1987;36:489-496 (Pubitemid 17099459)
15. Saravia NG, Weigle K, Navas C, et al. Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania Viannia in Colombia. Am J Trop Med Hyg 2002; 66:738-744
16. Saravia NG, Segura I, Holguin AF, Santrich C, Valderrama L, Ocampo C. Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania (Viannia) in Colombia. Am J Trop Med Hyg 1998;59:86-94.
17. Vergel C, Walker J, Saravia NG. Amplification of human DNA by primers targeted to Leishmania kinetoplast DNA and post-genome considerations in the detection of parasites by a polymerase chain reaction. Am J Trop Med Hyg 2005; 72:423-429
18. Weigle KA, Labrada LA, Lozano Q Santrich C, Barker DC. PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia). J Clin Microbiol 2002; 40:601-606
19. Ovalle Bracho C, Porras de Quintana L, Muvdi Arenas S, Rios Parra M. Polymerase chain reaction with two molecular targets in mucosal leishmaniasis' diagnosis: a validation study. Mem Inst Oswaldo Cruz 2007; 102:549-554
20. 20. Blackwell JM. Tumour necrosis factor alpha and mucocutaneous leishmaniasis. Parasitol Today 1999; 15:73-75 (Pubitemid 29341428)
21. 21. Bacellar O, Lessa H, Schriefer A, et al. Up-regulation of Thl-type responses in mucosal leishmaniasis patients. Infect Immun 2002; 70: 6734-6740 (Pubitemid 35387904)
22. Naik SR, Vinayak VK, Talwar P, et al. Visceral leishmaniasis masquerading as a nasopharyngeal tumour. Report of a case. Trans R Soc Trop Med Hyg 1978; 72:43-45
23. Balkhair A, Ben Abid F. Gastric and cutaneous dissemination of visceral leishmaniasis in a patient with advanced HIV Int J Infect Dis 2008; 12:111-113
24. Mebrahtu YB, Hendricks LD, Oster CN, et al. Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis patients in Kenya. Am J Trop Med Hyg 1993; 48:530-535
25. Dechant W, Rees PH, Kager PA, Klauss V, Adala H. Post kala-azar uveitis. Br J Ophthalmol 1980; 64:680-683
26. 26. Hoyama E, Schellini SA, Stolf HO, Nakajima V. Lacrimal excretory system sequelae in patients treated for leishmaniasis. Arq Bras Oftalmol 2006;69:333-337 (Pubitemid 44027752)
27. 27. Guerreiro JB, Cruz AA, Barrai A, Lessa HA, Rocha H, Carvalho EM. Mucosal leishmaniasis: quantitative nasal cytology as a marker of disease activity and indicator of healing. Ann Otol Rhinol Laryngol 2000; 109:89-94. (Pubitemid 30051788)
28. Forkner CE, Zia LS. Viable Leishmania donovani in nasal and oral secretions of patients with kala-azar and the bearing of this finding on the transmission of the disease. J Exp Med 1934; 59:491-499 Available at: http://jem.rupress.org/cgi/reprint/59/4/491. Accessed 17 June 2009.
29. 29. Kouyialis S, Archontakis S, Bilinis C, et al. Report of an atypical case of leishmaniasis presented as acute tonsillitis in an immunocompetent patient. Scand J Infect Dis 2005;37:916-918 (Pubitemid 43078104)
30. Schubach A, Haddad F, Oliveira-Neto MP, et al. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 1998; 178:911-914
31. Bowdre JH, Campbell JL, Walker DH, Tart DE. American mucocutaneous leishmaniasis. Culture of a Leishmania species from peripheral blood leukocytes. Am J Clin Pathol 1981; 75:435-438